Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Switzerland Health Monitor.

Medical Device Distribution Services Market to Reach $263.6 Billion by 2029 with 7.5% CAGR
The Business Research Company’s Medical Device Distribution Services Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 22, 2025 /EINPresswire.com/ -- Get 30% Off All...

Synthetic Small Molecule Active Pharmaceutical Ingredients Global Market Report 2025 | Development Factors till 2029
The Business Research Company's Synthetic Small Molecule Active Pharmaceutical Ingredients (APIs) Global Market Report 2025 – Market Size and Trends LONDON, GREATER LONDON, UNITED KINGDOM, August 22, 2025 /EINPresswire.com/ -- How Much Is The...

Legendary Swiss Brand BILATTE Ushers In Home Medical Beauty Care 3.0 Era
MONTREUX, Switzerland, Aug. 22, 2025 (GLOBE NEWSWIRE) -- BILATTE, a legendary medical research and recuperation brand originating from Montreux, Switzerland, known as the "global anti-aging holy land", announced today the revolutionary opening of...

Dr. Nikola Cihoric Redefines Clinical Research Through Innovation, Technology, and Data
ZURICH, SWITZERLAND, August 21, 2025 /EINPresswire.com/ -- Bridging Medicine, Research, and Technology for Patient-Centric Solutions Dr. Nikola Cihoric, founder and visionary behind Wemedoo AG, is redefining clinical research by merging...

Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD) Approval is based on comprehensive analytical,...

TRYVIO™ (aprocitentan) now included in ACC/AHA Clinical Practice Guidelines for the treatment of hypertension
The updated recommendations now include TRYVIO™ (aprocitentan) – the first and only hypertension treatment targeting the endothelin pathway. Endothelin is upregulated in hypertension and is a fundamental mediator in patients whose hypertension is...

Memo Therapeutics AG Publishes Phase I Safety, Tolerability, and Pharmacokinetics Study for Neutralizing Antibody Targeting BKPyV Infection in Clinical and Translational Science
First-in-human, Phase I, randomized, placebo-controlled study, successfully demonstrated safety and tolerability of potravitug in healthy volunteers The Company recently announced the results from its Phase II placebo-controlled clinical trial of...

ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The investigational device exemption (IDE) allows initiation of a global pivotal study designed to assess the...

Medical Tubing Market worth $18.41 billion by 2030, at a CAGR of 8.0%, says MarketsandMarkets™
Delray Beach, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The Medical Tubing Market is projected to reach USD 18.41 billion by 2030 from USD 12.53 billion in 2025, at a CAGR of 8.0% during the forecast period. The market for medical tubing is expanding...

Clinical Microbiology Market to Reach $6.9 Billion by 2029, Driven by Advanced Diagnostics and Regulatory Demand | MarketsandMarkets™.
Delray Beach, FL, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Stringent quality standards, technological innovation, and global healthcare expansion accelerate market growth The global clinical microbiology market, valued at US$4.8 billion in 2023, stood at...

Matchspace Music Reveals in New Study the Reality of Music Teaching in Switzerland
Zurich, Switzerland , Aug. 14, 2025 (GLOBE NEWSWIRE) -- Matchspace Music, the largest platform for music education in Switzerland, today announced the results of its annual Tune Barometer survey, capturing responses from nearly 400 music teachers...

Basilea announces in-licensing of a novel clinical phase 3-ready oral antibiotic
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, August 14, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and...

Black Bastion Group CEO Fady Riad: $2.1 Billion of Swiss Direct Investments in Egypt
GENEVA, SWITZERLAND, August 13, 2025 /EINPresswire.com/ -- Swiss and Egyptian business leaders are highlighting the robust economic partnership between Switzerland and Egypt, with cumulative Swiss direct investments reaching $2.1 billion across...

Medic group states Thousands will die in Sudan
(MENAFN) Thousands of people in Sudan’s war-torn North Darfur are at risk of dying due to severe shortages of vital medicines, the Sudan Doctors Network (SDN) warned Tuesday. The group said hospitals in the regional capital, El Fasher, are running...

Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®
BERKELEY, Calif. and MAINZ, Germany, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announces today that...

Human Blood Products Market to Reach USD 76.36 Billion by 2034, Says Towards Healthcare Research
Ottawa, Aug. 12, 2025 (GLOBE NEWSWIRE) -- According to a study published by Towards Healthcare, a sister firm of Precedence Research, the global human blood products market size stood at USD 45.82 billion in 2024 and is expected to surge...

Latest Research Offers New Insights into Early Breastfeeding Outcomes, Featured as Open Access in Breastfeeding Medicine through Medela
BAAR, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Medela, the brand trusted by millions of moms worldwide and the #1 brand in hospitals1, today announced the publication of the July 2025 Special Issue of Breastfeeding Medicine, titled “Early,...

Global Regenerative Medicine Market Set to Triple, Reaching $49.0 Billion by 2028 | MarketsandMarkets™.
Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The global regenerative medicine market, valued at US$13.5 billion in 2022, stood at US$16.0 billion in 2023 and is projected to advance at a resilient CAGR of 25.1% from 2023 to 2028,...

Mabylon AG Raises CHF 30 Million to Advance Peanut Allergy Lead Program MY006 to Clinical Proof-of-Concept
Funding combines equity investment and convertible loan Focus on best-in-class, clinical-stage peanut allergen neutralizing antibody Further potential for developing Mabylon’s discovery and pre-clinical pipeline programs Dr. Thomas Hecht has...

Microwave Ablation Devices Industry Report: Competitive Landscape and Future Prospects
The Business Research Company's Microwave Ablation Devices Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 22, 2025 /EINPresswire.com/ -- How Big Is The Microwave...